Interní Med. 2015; 17(4): 204-205

How to deal with a non-compliant hypertensive patient, or The path is not always easy

MUDr.Eva Kociánová, doc.MUDr.Jan Václavík, Ph.D.
I. interní klinika &ndash, kardiologická, FN Olomouc

The goal of hypertension management is undoubtedly to reduce the risk of its complications. For this purpose, there is a wide variety

of effective antihypertensive drugs. With their help, the vast majority of patients reach the recommended target blood pressure levels.

However, the willingness of a particular patient to adhere to the prescribed therapeutic regimen in the long term has proved to be a

major issue. When non-compliance is identified, it is essential to critically evaluate all the tablets administered in terms of their necessity

and efficacy, to use fixed combinations, whenever possible, and, in particular, to make rigorous efforts in motivating the patient for

lifelong treatment.

Keywords: hypertension, non-compliance, serum antihypertensive drug levels, hypertension complications

Published: September 19, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kociánová E, Václavík J. How to deal with a non-compliant hypertensive patient, or The path is not always easy. Interní Med. 2015;17(4):204-205.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Filipovský J, Widimský jr. J, Ceral J, et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Hyperten Kardiovas Prev 2012? 3: 1-16.
    2. Mancia G, Farad R, Narkiewicz K, et al; 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertension 2013; 31: 1281-1357. Go to original source... Go to PubMed...
    3. The ONTARGET Investigators Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. N Engl J Med 2008; 358: 1547-1559. Go to original source... Go to PubMed...
    4. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120: 713-719. Go to original source... Go to PubMed...
    5. Chalmers J, Arima H, Woodward M, et al. Effects of combination of Perindopril, Indapamide and calcium chanel blockers in patients with type 2 diabetes mellitus. Result from the ADVANCE Trial. Hypertens 2014; 63: 259-264. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.